daratumumab,ixazomib
janssen,takeda
['daratumumab', 'ixazomib', 'mmsm']
aa15: ixazomib and daratumumab without dex in elderly frail rrmm patients:
- analysis of single arm phase ii
- early relapse myeloma - rr: 70%, vgpr and better 32%
- mpfs:18.5 months
- mos: nr
#mmsm #myeloma #usmirc #asco23 #medtwitter #meded 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter